Online citations, reference lists, and bibliographies.
← Back to Search

Mutants Of Escherichia Coli Heat-labile Toxin Lacking ADP-ribosyltransferase Activity Act As Nontoxic, Mucosal Adjuvants.

G. Douce, C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, G. Dougan
Published 1995 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A nontoxic mutant (LTK7) of the Escherichia coli heat-labile enterotoxin (LT) lacking ADP-ribosylating activity but retaining holotoxin formation was constructed. By using site-directed mutagenesis, the arginine at position 7 of the A subunit was replaced with lysine. This molecule, which was nontoxic in several assays, was able to bind to eukaryotic cells and acted as a mucosal adjuvant for co-administered proteins; BALB/c mice immunized intranasally with LTK7 and ovalbumin developed high levels of serum and local antibodies to ovalbumin and toxin. In addition, mice immunized intranasally with fragment C of tetanus toxin and LTK7 were protected against lethal challenge with tetanus toxin. Thus nontoxic mutants of heat-labile toxin can act as effective intranasal mucosal adjuvants.
This paper references



This paper is referenced by
10.1007/s10989-019-10013-6
Immunoinformatics Approach to Engineer a Potent Poly-epitope Fusion Protein Vaccine Against Coxiella burnetii
Ehsan Rashidian (2020)
10.1172/JCI122110
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
Y. Sui (2019)
10.3389/fcimb.2019.00292
Review of Newly Identified Functions Associated With the Heat-Labile Toxin of Enterotoxigenic Escherichia coli
Qiangde Duan (2019)
10.1080/14760584.2018.1507743
Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
K. Sano (2018)
10.1016/B978-0-323-35761-6.00066-3
66 – Technologies for Making New Vaccines
S. S. Ahmed (2018)
10.1080/14760584.2016.1182868
Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants
Yongping Ma (2016)
10.3389/fimmu.2016.00602
Plague Vaccine Development: Current Research and Future Trends
S. Verma (2016)
Biotinylated peptide nanofibers for modulating the immune response
Şehmus Tohumeken (2016)
10.1155/2016/1459394
Adjuvants: Classification, Modus Operandi, and Licensing
Juliana de Souza Apostólico (2016)
10.1016/j.vetmic.2016.03.001
Attenuated Salmonella Typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus.
Xueyan Liu (2016)
Mechanisms and Performances of Adjuvants in Vaccine Immunogenicity
S. Gheibihayat (2015)
10.1016/B978-0-12-415847-4.00061-6
Mucosal Adjuvants: New Developments and Challenges
L. C. Freytag (2015)
10.3109/08820139.2015.1070268
Comparing Antibody Responses in Chickens Against Plasmodium falciparum Lactate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase with Freund’s and Pheroid® Adjuvants
Robert G E Krause (2015)
10.3384/DISS.DIVA-117981
Nasal vaccination using novel mucosal adjuvants - with main focus on influenza A virus
T. Falkeborn (2015)
10.1080/21645515.2015.1026498
The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses
K. Bagley (2015)
Resposta imune humoral em bovinos induzida pela glicoproteína D recombinante de herpesvírus bovino tipo 5
Itauá Leston Araujo (2014)
10.1128/microbiolspec.TBS-0011-2012
Spore Surface Display.
R. Isticato (2014)
10.1111/apm.12143
An overview of adjuvant formulations and delivery systems
Alexis García (2014)
10.4172/2155-9899.1000225
The Quest for an HIV-1 Vaccine Adjuvant: Bacterial Toxins as New Potential Platforms
T. Nashar (2014)
Immunity without Intracellular Trafficking Cholera Toxin Adjuvants: Enhanced A Second Generation of Double Mutant
Jerry R. Mcghee (2013)
of heat-labile enterotoxin. derivatives and protease sensitivity of nontoxic Mutations in the A subunit affect yield, stability,
Roberto Rappuoli (2013)
10.1016/B978-1-4557-0090-5.00013-6
60 – Technologies for making new vaccines
R. Ellis (2013)
10.1128/JVI.03531-12
Immunogenicity of a Vaccine Regimen Composed of Simian Immunodeficiency Virus DNA, rMVA, and Viral Particles Administered to Female Rhesus Macaques via Four Different Mucosal Routes
Mariana Manrique (2013)
10.1007/978-1-4614-5380-2_3
Mucosal Vaccination: Opportunities and Challenges
O. Borges (2013)
10.1186/1475-2859-12-98
Non-recombinant display of the B subunit of the heat labile toxin of Escherichia coli on wild type and mutant spores of Bacillus subtilis
R. Isticato (2013)
Mucosal IgA Responses Receptor Signaling Is Critical for β TGF
C. Guzmán (2013)
10.2165/00003495-199652060-00002
Prospects for the Development of a Vaccine Against Helicobacter pylori
J. Telford (2012)
10.5772/33383
E. coli Alpha Hemolysin and Properties
Bakás Laura (2012)
10.1007/BF03259304
Helicobacter pylori Vaccine
D. M. Chen (2012)
10.1186/1297-9716-43-56
Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge
Xia Yu (2012)
10.1128/CVI.00538-10
Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant
E. Norton (2011)
Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
J. Erume (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar